Maxim Group initiated coverage on Palisade Bio with a new price target
$PALI
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
Maxim Group initiated coverage of Palisade Bio with a rating of Buy and set a new price target of $7.00